A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health

NCT04293523 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: ELOCTA

Sponsor

Swedish Orphan Biovitrum